UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of ~~the~~

The Securities Exchange Act of 1934

~~July~~August 2118, 2009

Date of Report (Date of earliest event reported)

BIOPURE CORPORATION

(Exact ~~Name~~name of ~~Registrant~~registrant as ~~Specified~~specified in ~~Charter)~~its charter)

Delaware	001-15167	04-2836871
DELAWARE	001-15167	04-2836871
(State or other Jurisdiction of Incorporation)	(Commission File No.)	(IRS Employer Identification No.)
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

11 Hurley Street, Cambridge, Massachusetts 02141

(Address of principal executive offices, including zip code)

(617) 234-6500

(Registrant’s telephone number, including area code)

~~(Former~~Check ~~Name~~the orappropriate ~~Former~~box ~~Address,~~below if ~~Changed~~the ~~Since~~Form ~~Last~~8-K ~~Report)~~filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 72.01. ~~Regulation~~Completion FDof ~~Disclosure~~Acquisition or Disposition of Assets.

On ~~July~~ August 2118, 2009 the United States Bankruptcy Court for the District of Massachusetts entered an Order (a) Approving Bid Procedures; (B) Authorizing and Scheduling an Auction; (C) Approving Payment of an Expense Reimbursement; (D) Establishing Procedures Relating to the Assumption and Assignment of Certain Executory Contracts and Unexpired Leases, ~~Including~~Biopure ~~Notice~~Corporation ofconcluded ~~Proposed Cure Amounts; (E) Approving~~ the ~~Form~~previously ~~and~~announced ~~Manner~~auction of ~~Notices;~~substantially ~~and~~all (F) Scheduling Sale Hearing (the “Order”). Pursuant to the Order, the court established August 13, 2009 at 4:00 p.m. as the bid deadline and the deadline to object to (i) the assumption and assignment of ~~contracts~~its ~~and~~assets ~~leases~~in ~~and~~connection ~~(ii) the~~with ~~proposed sale. An~~its ~~auction~~bankruptcy ~~has been scheduled for August 18, 2009 at 10:00 a~~proceedings.~~m. The~~ ~~sale hearing is scheduled for August 20, 2009 at 2:00 p.m. Further information and copies of the relevant documents may be obtained at www.craigmacauley.com.~~

OPK Biotech LLC will purchase substantially all of Biopure’s operating assets pursuant to an asset purchase agreement (APA) for a purchase price of $4,050,000. The bankruptcy court has approved this purchase and sale, which remains subject to customary closing conditions and certain purchase price adjustments. Biopure also designated a lower bid as a “back-up” bid pursuant to bidding procedures previously approved by the bankruptcy court.

Biopure will work diligently with OPK to close the sale in the next 30 days.

On the same auction date, an affiliate of OPK agreed to purchase Biopure’s 50% interest in a partnership that owns the building housing Biopure’s headquarters and some laboratory space for $850,000, subject to bankruptcy court approval, which is expected to be sought in early September, and subject to closing conditions. Biopure also designated a lower bid as a “back-up” bid pursuant to the bidding procedures.

Biopure does not expect that Biopure stockholders will receive any substantial distributions resulting from these transactions and expects that the bankruptcy proceedings will ultimately result in the cancellation of these equity interests.

Further information and copies of the relevant documents may be obtained at www.craigmacauley.com/BiopurePleadings.html.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~Registrant~~registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

BIOPURE CORPORATION

Biopure Corporation

Date: July 24, 2009

/s/ Zafiris G. Zafirelis

Dated: August 24, 2009

/s/ Zafiris G. Zafirelis

Zafiris G. Zafirelis

~~Zafiris G. Zafirelis~~

Chief Executive Officer

~~Chief Executive Officer~~

Filing Compare · BIOPURE CORP